| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
|
Middelberg, Anton P.J.
|
|
2011
|
29 |
41 |
p. 7154-7162
9 p.
|
article
|
| 2 |
ANNOUNCEMENT: VACCINE TECHNOLOGY IV
|
|
|
2011
|
29 |
41 |
p. 7218-
1 p.
|
article
|
| 3 |
Cloning and expression of protease ClpP from Streptococcus pneumoniae in Escherichia coli: Study of the influence of kanamycin and IPTG concentration on cell growth, recombinant protein production and plasmid stability
|
Einsfeldt, Karen
|
|
2011
|
29 |
41 |
p. 7136-7143
8 p.
|
article
|
| 4 |
Editorial Board
|
|
|
2011
|
29 |
41 |
p. CO2-
1 p.
|
article
|
| 5 |
Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells
|
Frensing, Timo
|
|
2011
|
29 |
41 |
p. 7125-7129
5 p.
|
article
|
| 6 |
Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: Linking systems biology with vaccine development
|
Adams, L. Garry
|
|
2011
|
29 |
41 |
p. 7197-7206
10 p.
|
article
|
| 7 |
Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome
|
Onions, D.
|
|
2011
|
29 |
41 |
p. 7117-7121
5 p.
|
article
|
| 8 |
Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines
|
Wei, Hung-Ju
|
|
2011
|
29 |
41 |
p. 7163-7172
10 p.
|
article
|
| 9 |
Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography
|
Spitteler, Marcelo A.
|
|
2011
|
29 |
41 |
p. 7182-7187
6 p.
|
article
|
| 10 |
Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine
|
Yan, Jian
|
|
2011
|
29 |
41 |
p. 7173-7181
9 p.
|
article
|
| 11 |
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
|
Bakker, Wilfried A.M.
|
|
2011
|
29 |
41 |
p. 7188-7196
9 p.
|
article
|
| 12 |
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
|
Camacho, A.I.
|
|
2011
|
29 |
41 |
p. 7130-7135
6 p.
|
article
|
| 13 |
Preservative of choice for Prev(e)nar 13™ in a multi-dose formulation
|
Khandke, Lakshmi
|
|
2011
|
29 |
41 |
p. 7144-7153
10 p.
|
article
|
| 14 |
Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero)
|
Paillet, Cristian
|
|
2011
|
29 |
41 |
p. 7212-7217
6 p.
|
article
|
| 15 |
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A
|
Cooper, David
|
|
2011
|
29 |
41 |
p. 7207-7211
5 p.
|
article
|
| 16 |
Vaccine stabilization: Research, commercialization, and potential impact
|
Kristensen, Debra
|
|
2011
|
29 |
41 |
p. 7122-7124
3 p.
|
article
|
| 17 |
Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010
|
Buckland, Barry C.
|
|
2011
|
29 |
41 |
p. 7115-7116
2 p.
|
article
|
Journal description